SEC Filing | The Allstate Corporation

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Prindiville Mark Q

(Last)

(First)

(Middle)

C/O THE ALLSTATE CORPORATION

2775 SANDERS RD.

(Street)

NORTHBROOK

60062

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/04/2020

3. Issuer Name and Ticker or Trading Symbol
ALLSTATE CORP [ ALL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
EVP & Chief Risk Officer - AIC

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	8,177	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (Right to Buy)	02/12/2017	02/12/2023	Common Stock	5,511	45.61	D
Employee Stock Option (Right to Buy)	02/18/2017	02/18/2024	Common Stock	4,016	52.18	D
Employee Stock Option (Right to Buy)	02/18/2018	02/18/2025	Common Stock	6,935	70.71	D
Employee Stock Option (Right to Buy)	02/11/2019	02/11/2026	Common Stock	7,383	62.32	D
Employee Stock Option (Right to Buy)	09/06/2019	09/06/2026	Common Stock	1,550	69.31	D
Employee Stock Option (Right to Buy)	02/09/2020	02/09/2027	Common Stock	9,662	78.35	D
Employee Stock Option (Right to Buy)	⁽¹⁾	02/22/2028	Common Stock	8,847	92.8	D
Employee Stock Option (Right to Buy)	⁽²⁾	02/08/2029	Common Stock	10,109	92.46	D
Employee Stock Option (Right to Buy)	⁽³⁾	10/03/2029	Common Stock	1,391	105.65	D
Employee Stock Option (Right to Buy)	⁽⁴⁾	02/19/2030	Common Stock	5,260	124.26	D
Restricted Stock Units	⁽⁵⁾	10/03/2022	Common Stock	210	0	D
Restricted Stock Units	⁽⁶⁾	02/19/2023	Common Stock	1,162	0	D

Explanation of Responses:

1. Stock option award granted on February 22, 2018, for 8,847 shares of common stock vesting in three equal increments. The first and second increments vested on February 22, 2019, and February 22, 2020. The remaining increment will vest on February 22, 2021.

2. Stock option award granted on February 8, 2019, for 10,109 shares of common stock vesting in three equal increments. The first increment vested on February 8, 2020. The remaining two increments will vest on February 8, 2021, and February 8, 2022.

3. Stock option award granted on October 3, 2019, for 1,391 shares of common stock vesting in three equal increments, with any fractional shares to be rounded as provided for in award agreement, on October 3, 2020, October 3, 2021, and October 3, 2022.

4. Stock option award granted on February 19, 2020, for 5,260 shares of common stock vesting in three equal increments, with any fractional shares to be rounded as provided for in award agreement, on February 19, 2021, February 19, 2022, and February 19, 2023.

5. Award of Restricted Stock Units (RSUs) granted on October 3, 2019, under The Allstate Corporation 2019 Equity Incentive Plan. Each RSU represents the right to receive, without the payment of any consideration, one share of Allstate common stock on the conversion date, which is October 3, 2022.

6. Award of Restricted Stock Units (RSUs) granted on February 19, 2020, under The Allstate Corporation 2019 Equity Incentive Plan. Each RSU represents the right to receive, without payment of any consideration, one share of Allstate common stock on the conversion date, with any fractional RSU to be rounded as provided for in award agreement. The RSUs will convert in three equal increments on February 19, 2021, February 19, 2022, and February 19, 2023.

	/s/ Efie Vainikos, attorney-in-fact for Mr. Prindiville	05/14/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.


			POWER OF ATTORNEY


      KNOW BY ALL THESE PRESENTS, that the undersigned hereby
constitutes and appoints each of Daniel G. Gordon, Sherie Lecaj,
Iman Naim, and Efie Vainikos, signing singly, the undersigned's
true and lawful attorney-in-fact to:

(1)	prepare, execute in the undersigned's name and on the
	undersigned's behalf, and submit to the U.S. Securities
	and Exchange Commission (the "SEC") a Form ID, including
	amendments thereto, and any other documents necessary or
	appropriate to obtain codes and passwords enabling the
	undersigned to make electronic filings with the SEC of
	reports required by Section 16(a) of the Securities
	Exchange Act of 1934 or any rule or regulation of the SEC;

(2)	execute for and on behalf of the undersigned, in the
	undersigned's capacity as an officer and/or director of
	The Allstate Corporation (the "Company"), Forms 3, 4, and 5
	in accordance with Section 16(a) of the Securities Exchange
	Act of 1934 and the rules thereunder; and any other forms
	or reports the undersigned may be required to file in
	connection with the undersigned's ownership, acquisition,
	or disposition of securities of the Company;

(3)	do and perform any and all acts for and on behalf of the
	undersigned which may be necessary or desirable to complete
	and execute any such Form 3, 4, or 5, or other form or
	report, and timely file such form or report with the SEC
	and any stock exchange or similar authority; and

(4)	take any other action of any type whatsoever in connection
	with the foregoing which, in the opinion of such attorney-
	in-fact, may be of benefit to, in the best interest of, or
	legally required by, the undersigned, it being understood
	that the documents executed by such attorney-in-fact on
	behalf of the undersigned pursuant to this Power of Attorney
	shall be in such form and shall contain such terms and
	conditions as such attorney-in-fact may approve in such
	attorney-in-fact's discretion.

      The undersigned hereby grants to each such attorney-in-fact
full power and authority to do and perform any and every act and thing
whatsoever requisite, necessary, or proper to be done in the exercise of
any of the rights and powers herein granted, as fully to all intents and
purposes as the undersigned might or could do if personally present, with
full power of substitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of this power
of attorney and the rights and powers herein granted.  The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving in such
capacity at the request of the undersigned, are not assuming, nor is
the Company assuming, any of the undersigned's responsibilities to
comply with Section 16 of the Securities Exchange Act of 1934.

      This Power of Attorney shall remain in full force and effect
until the undersigned is no longer required to file Forms 3, 4, and 5 with
respect to the undersigned's holdings of and transactions in securities
issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.

      IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 30th day of April, 2020.





				_/s/ Mark Q. Prindiville__________

				__Mark Q. Prindiville_____________
				Print Name